{
    "2019-03-15": [
        [
            {
                "time": "2023-10-15",
                "original_text": "Pharma Stock Roundup: Regulatory Updates From MRK, PFE, J&J, AGN & Others",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Regulatory",
                        "MRK",
                        "PFE",
                        "J&J",
                        "AGN"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "The Case Against Pfizer Stock and the Rest of the Industry",
                "features": {
                    "keywords": [
                        "Case",
                        "Against",
                        "Pfizer",
                        "Industry"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}